A Recent Memorandum of Understanding Between FDA and CMS To Facilitate Information Sharing May Accelerate Approval and Coverage Decisions for FDA-Regulated Products

Recently, FDA Commissioner Margaret Hamburg signed a Memorandum of Understanding (MOU) with the Centers for Medicare & Medicaid Services (CMS) to “promote initiatives related to the review and use of FDA-regulated drugs, biologics, medical devices, and foods, including dietary substances.” MOU 225-10-0010 (June 25, 2010) can be found here.

Click the link below to read the full alert.